Seleccione un Tamaño
| Tamaño de envase | SKU | Disponibilidad | Precio |
|---|---|---|---|
| 5 μg | Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad | 549,00 € |
Acerca de este artículo
549,00 €
biological source
human
Quality Segment
assay
>95% (total protein)
form
liquid
specific activity
250-300 mU/mg
manufacturer/tradename
Chemicon®
concentration
0.2 μg/μL
NCBI accession no.
UniProt accession no.
shipped in
dry ice
Gene Information
human ... MMP13(4322)
General description
ProMMP-13 [Procollagenase-3] consists of 452 amino acids with a calculated Mr of 52.520 [Freije et al., 1994]. Due to N-linked glycosylation, the actual Mr is about 60000 Da [Knauper et al., 1996]. Within the protein the following domains and sequence regions can be distinguished [Freije et al., 1994; Knauper et al., 1996]: An N-terminal propeptide, which confers latency to the proenzyme, a Ca2+ and Zn2+-ion binding catalytic domain, a hinge region, and a C-terminal hemopexin-like domain. Latent procollagenase-3 can be activated by proteases such as stromelysin [ Knauper et al., 1996], gelatinase A, MT1-MMP and plasmin [ Knauper et al., 1996] or incubation with APMA Knauper et al., 1996]. The Mr of active collagenase-3 which begins with the N-terminal sequence YNVFPRTL is 48,000 Da.
Collagenase-3 hydrolyzes type II collagen 5- to 6- times faster than type I and type III collagens. The enzyme also exhibits high activity towards gelatin and it degrades SERPINS as a1-antichymotrypsin and plasminogen activator inhibitor-2 [Knauper et al., 1996]. Collagenase-3 is inhibited in a 1:1 stoichiometric fashion by TIMP-1, TIMP-2 and TIMP-3.
Collagenase-3 is expressed during fetal bone development [Stahlebackdahl, 1997]. In adult human tissues collagenase-3 has been detected only in pathological conditions: in malignant tumors [Freije et al., 1994], in chronic ulcers [Valaamo et al., 1997], in arthritic cartilage [Mitchell et al., 1996] and synovium [Wernicke et al., 1996].
Application
An aliquot of 19.5 μL procollagenase-3 is mixed with 0.5 μL APMA solution (40 mM p-aminophenyl mercuric acetate in DMSO) and the mixture is incubated for 30 minutes at 37°C. The mixture may be stored on ice until use for activity assays.
INHIBITORS:
MMP-13 is inhibited by TIMPs and by chelators of divalent cations such as EDTA or o-phenanthroline.
Physical form
Preparation Note
Analysis Note
Other Notes
Legal Information
Disclaimer
1 of 1
Este artículo | |||
|---|---|---|---|
| assay >95% (total protein) | assay - | assay - | assay ≥90% (SDS-PAGE) |
| Gene Information human ... MMP13(4322) | Gene Information human ... MMP13(4322) | Gene Information human ... MMP14(4323) | Gene Information - |
| specific activity 250-300 mU/mg | specific activity - | specific activity - | specific activity ≥50 mU/mg protein |
| biological source human | biological source rabbit | biological source human | biological source - |
| concentration 0.2 μg/μL | concentration ~1 mg/mL | concentration 0.2 μg/μL | concentration - |
| form liquid | form buffered aqueous solution | form liquid | form liquid |
Clase de almacenamiento
12 - Non Combustible Liquids
wgk
WGK 1
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
A Chemicon comparative chart showing MMPs, classifications, weights, activating agents, conditions and related references.
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| CC1047 | 04053252277078 |



